A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain
Hagen, N A, Lapointe, B, Ong-Lam, M, Dubuc, B, Walde, D, Gagnon, B, Love, R, Goel, R, Hawley, P, Ngoc, A Ho, du Souich, P
Published in Current oncology (Toronto) (01.06.2011)
Published in Current oncology (Toronto) (01.06.2011)
Get full text
Journal Article
P.021 Evaluation of PREEMPT fixed-dose, fixed-site and follow the pain treatment paradigms in the PREDICT Study
Graboski, C, Ong-Lam, M, Becker, W, Boudreau, G, Davidovic, G, Ma, J, Sommer, K, Finkelstein, I
Published in Canadian journal of neurological sciences (01.06.2022)
Published in Canadian journal of neurological sciences (01.06.2022)
Get full text
Journal Article
P.011 OnabotulinumtoxinA, quality of life, health resource utilization, and work productivity in chronic migraine: interim results from PREDICT
Boudreau, G, Becker, WJ, Graboski, C, Ong-Lam, M, Finkelstein, I, Christie, S, Bhogal, M, Davidovic, G
Published in Canadian journal of neurological sciences (01.06.2019)
Published in Canadian journal of neurological sciences (01.06.2019)
Get full text
Journal Article
Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study
Hagen, Neil A., MD, FRCPC, du Souich, Patrick, MD, PhD, Lapointe, Bernard, MD, Ong-Lam, May, MD, FRCPC, Dubuc, Benoit, MD, Walde, David, MD, FRCPC, Love, Robin, MD, CCFP, Ngoc, Anh Ho, PhD
Published in Journal of pain and symptom management (01.04.2008)
Published in Journal of pain and symptom management (01.04.2008)
Get full text
Journal Article